Related Experiment Video
Updated: May 3, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
[Clinicopathological characteristics and prognosis of malignant pleural mesothelioma]
Wen-hui Chen1, Xue-li Zhang1, Hua-ping Dai1
1Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Objective:
To investigate the clinicopathological characteristics and prognosis of malignant pleural mesothelioma.
Methods:
Thirty patients with malignant pleural mesothelioma diagnosed between January 2006 and June 2012 in our hospital were studied retrospectively. Clinical manifestations, radiological characteristics, endoscopic features, histopathology, and survival status were analyzed.
Results:
There were 15 males and 15 females, with a median age of 58 years. The commonest clinical symptoms were dyspnea on exertion (26 cases), followed by chest pain (15 cases). The main radiological manifestations were small to large amount of pleural effusions (28 cases), often accompanied by pleural thickening and/or pleural nodules.Of the 30 cases, 25 were diagnosed through medical thoracoscopy and 1 through surgical thoracoscopy. Thoracic lesions manifested as nodules of diffuse distribution on the diaphragmatic pleura and parietal pleura.Some pleural surface was covered with lesions like white tiles.Histopathological examination showed epithelial type in 24 cases, sarcomatoid type in 5 and biphasic type in 1 case.Immonohistological examination showed that the positive rates of calretinin, MC, D2∼40 were 27, 25 and 19 cases respectively.Fifteen patients received chemotherapy, 2 underwent pleurectomy, and 8 were treated with best supportive care. Twenty-four patients were followed for 1 month to 6 years, and 6 patients were lost.Overall survival time was 1-54 months. Those who survived longer than 24 months received chemotherapy with pemetrexed and cisplatin/carboplatin or pleurectomy.
Conclusions:
Clinical manifestations of malignant pleural mesotheliome were nonspecific, medical thoracoscopy can make early diagnosis. The pathological diagnosis of malignant pleural mesothelioma was based on immunohistochemical examination, calretinin, MC and D2-40 had positive diagnostic value. Malignant pleural mesothelioma had poor prognosis, chemotherapy with pemetrexed and cisplatin/carboplatin could prolong the survival time of the patients.
Insights
Malignant pleural mesothelioma presents with nonspecific symptoms, but medical thoracoscopy aids early diagnosis. Chemotherapy with pemetrexed and cisplatin/carboplatin can improve survival for this aggressive cancer.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Malignant pleural mesothelioma is a rare but aggressive cancer.
- Early diagnosis and effective treatment strategies are crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the clinicopathological features of malignant pleural mesothelioma.
- To evaluate the diagnostic utility of medical thoracoscopy and immunohistochemistry.
- To assess the prognostic factors and treatment efficacy for malignant pleural mesothelioma.
Main Methods:
- Retrospective analysis of 30 patients diagnosed with malignant pleural mesothelioma.
- Review of clinical, radiological, endoscopic, and histopathological data.
- Evaluation of immunohistochemical markers (calretinin, MC, D2-40) and survival status.
Main Results:
- Common symptoms include dyspnea and chest pain; radiological findings often show pleural effusions and thickening.
- Medical thoracoscopy facilitated diagnosis in 25 out of 30 cases.
- Epithelial type was most common (24 cases), with positive rates for calretinin, MC, and D2-40.
- Patients receiving chemotherapy (pemetrexed and cisplatin/carboplatin) or pleurectomy showed prolonged survival.
Conclusions:
- Malignant pleural mesothelioma has nonspecific clinical manifestations, underscoring the importance of medical thoracoscopy for early diagnosis.
- Immunohistochemistry, particularly using calretinin, MC, and D2-40, is vital for pathological confirmation.
- The disease has a poor prognosis, but combination chemotherapy with pemetrexed and cisplatin/carboplatin or surgical intervention may extend survival.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Atypical Pneumonia
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...

